Bansback NJ - Search Results

1

Exploring the validity of estimating EQ-5D and SF-6D utility values from the health assessment questionnaire in patients with inflammatory arthritis.

Harrison MJ, Lunt M, Verstappen SM, Watson KD, Bansback NJ, Symmons DP. Harrison MJ, et al. Among authors: bansback nj. Health Qual Life Outcomes. 2010 Feb 11;8:21. doi: 10.1186/1477-7525-8-21. Health Qual Life Outcomes. 2010. PMID: 20149253 Free PMC article.

2

The comparative responsiveness of the EQ-5D and SF-6D to change in patients with inflammatory arthritis.

Harrison MJ, Davies LM, Bansback NJ, McCoy MJ, Verstappen SM, Watson K, Symmons DP; British Society for Rheumatology Biologics Register Control Centre Consortium. Harrison MJ, et al. Among authors: bansback nj. Qual Life Res. 2009 Nov;18(9):1195-205. doi: 10.1007/s11136-009-9539-2. Epub 2009 Sep 24. Qual Life Res. 2009. PMID: 19777373 Free PMC article.

3

The validity and responsiveness of generic utility measures in rheumatoid arthritis: a review.

Harrison MJ, Davies LM, Bansback NJ, Ingram M, Anis AH, Symmons DP. Harrison MJ, et al. Among authors: bansback nj. J Rheumatol. 2008 Apr;35(4):592-602. Epub 2008 Feb 15. J Rheumatol. 2008. PMID: 18278841 Review.

4

Why do patients with inflammatory arthritis often score states "worse than death" on the EQ-5D? An Investigation of the EQ-5D classification system.

Harrison MJ, Davies LM, Bansback NJ, McCoy MJ, Farragher TM, Verstappen SM, Hassell A, Symmons DP. Harrison MJ, et al. Among authors: bansback nj. Value Health. 2009 Sep;12(6):1026-34. doi: 10.1111/j.1524-4733.2009.00565.x. Epub 2009 May 15. Value Health. 2009. PMID: 19473335 Free article.

5

Valuing health for clinical and economic decisions: directions relevant for rheumatologists.

Harrison MJ, Bansback NJ, Marra CA, Drummond M, Tugwell PS, Boonen A. Harrison MJ, et al. Among authors: bansback nj. J Rheumatol. 2011 Aug;38(8):1770-5. doi: 10.3899/jrheum.110404. J Rheumatol. 2011. PMID: 21807800

6

Estimating the cost and health status consequences of treatment with TNF antagonists in patients with psoriatic arthritis.

Bansback NJ, Ara R, Barkham N, Brennan A, Fraser AD, Conway P, Reynolds A, Emery P. Bansback NJ, et al. Rheumatology (Oxford). 2006 Aug;45(8):1029-38. doi: 10.1093/rheumatology/kel147. Epub 2006 Jun 16. Rheumatology (Oxford). 2006. PMID: 16782734

7

An overview of economic evaluations for drugs used in rheumatoid arthritis : focus on tumour necrosis factor-alpha antagonists.

Bansback NJ, Regier DA, Ara R, Brennan A, Shojania K, Esdaile JM, Anis AH, Marra CA. Bansback NJ, et al. Drugs. 2005;65(4):473-96. doi: 10.2165/00003495-200565040-00004. Drugs. 2005. PMID: 15733011 Review.

8

A prognostic model for functional outcome in early rheumatoid arthritis.

Bansback N, Young A, Brennan A, Dixey J. Bansback N, et al. J Rheumatol. 2006 Aug;33(8):1503-10. J Rheumatol. 2006. PMID: 16832851

9

Biologic drugs for rheumatoid arthritis in the Medicare program: a cost-effectiveness analysis.

Wailoo AJ, Bansback N, Brennan A, Michaud K, Nixon RM, Wolfe F. Wailoo AJ, et al. Arthritis Rheum. 2008 Apr;58(4):939-46. doi: 10.1002/art.23374. Arthritis Rheum. 2008. PMID: 18383356 Free article.

10

Understanding the side effects of glucocorticoid therapy: shining a light on a drug everyone thinks they know.

Dixon WG, Bansback N. Dixon WG, et al. Ann Rheum Dis. 2012 Nov;71(11):1761-4. doi: 10.1136/annrheumdis-2012-202021. Epub 2012 Jul 31. Ann Rheum Dis. 2012. PMID: 22851467

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters